289 related articles for article (PubMed ID: 24967375)
1. Disease activity in psoriatic arthritis: comparison of the discriminative capacity and construct validity of six composite indices in a real world.
Salaffi F; Ciapetti A; Carotti M; Gasparini S; Gutierrez M
Biomed Res Int; 2014; 2014():528105. PubMed ID: 24967375
[TBL] [Abstract][Full Text] [Related]
2. Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population.
Michelsen B; Diamantopoulos AP; Høiberg HK; Soldal DM; Kavanaugh A; Haugeberg G
J Rheumatol; 2017 Apr; 44(4):431-436. PubMed ID: 28148701
[TBL] [Abstract][Full Text] [Related]
3. Gender does not make a difference in "composite psoriatic disease activity index (CPDAI)" in patients with psoriatic arthritis.
Kenar G; Yarkan H; Zengin B; Can G; Birlik M; Önen F
Rheumatol Int; 2018 Nov; 38(11):2069-2076. PubMed ID: 30194455
[TBL] [Abstract][Full Text] [Related]
4. Disparity between ultrasound and clinical findings in psoriatic arthritis.
Husic R; Gretler J; Felber A; Graninger WB; Duftner C; Hermann J; Dejaco C
Ann Rheum Dis; 2014 Aug; 73(8):1529-36. PubMed ID: 23740228
[TBL] [Abstract][Full Text] [Related]
5. Comparison of disease activity measures in early psoriatic arthritis in usual care.
Wervers K; Luime JJ; Tchetverikov I; Gerards AH; Kok MR; Appels CWY; van der Graaff WL; van Groenendael JHLM; Korswagen LA; Veris-van Dieren JJ; Hazes JMW; Vis M;
Rheumatology (Oxford); 2019 Dec; 58(12):2251-2259. PubMed ID: 31211399
[TBL] [Abstract][Full Text] [Related]
6. Ultrasonographic evaluation in psoriatic arthritis is of major importance in evaluating disease activity.
Michelsen B; Diamantopoulos AP; Hammer HB; Soldal DM; Kavanaugh A; Haugeberg G
Ann Rheum Dis; 2016 Dec; 75(12):2108-2113. PubMed ID: 27091837
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Composite Indices Tailored for Psoriatic Arthritis Treated with csDMARD and bDMARD: A Cross-sectional Analysis of a Longitudinal Cohort.
Lubrano E; De Socio A; Perrotta FM
J Rheumatol; 2017 Aug; 44(8):1159-1164. PubMed ID: 28572467
[TBL] [Abstract][Full Text] [Related]
8. Remission criteria and activity indices in psoriatic arthritis.
Acosta Felquer ML; Ferreyra Garrott L; Marin J; Catay E; Scolnik M; Scaglioni V; Ruta S; Rosa J; Soriano ER
Clin Rheumatol; 2014 Sep; 33(9):1323-30. PubMed ID: 24820142
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Composite Measure Remission Targets in Psoriatic Arthritis.
Farkas F; Ikumi N; Elmamoun M; Szentpetery A; FitzGerald O
J Rheumatol; 2021 Aug; 48(8):1272-1278. PubMed ID: 33722944
[TBL] [Abstract][Full Text] [Related]
10. Composite Measures of Disease Activity in Psoriatic Arthritis: Comparative Instrument Performance Based on the Efficacy of Guselkumab in an Interventional Phase II Trial.
Helliwell PS; Deodhar A; Gottlieb AB; Boehncke WH; Xu XL; Xu S; Wang Y; Hsia EC; Gladman DD; Ritchlin CT
Arthritis Care Res (Hoboken); 2020 Nov; 72(11):1579-1588. PubMed ID: 31421033
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices.
Lubrano E; Scriffignano S; Azuaga AB; Ramirez J; Cañete JD; Perrotta FM
RMD Open; 2020 Mar; 6(1):. PubMed ID: 32179713
[TBL] [Abstract][Full Text] [Related]
12. Residual symptoms and disease burden among patients with psoriatic arthritis: is a new disease activity index required?
Kilic G; Kilic E; Nas K; Kamanlı A; Tekeoglu İ
Rheumatol Int; 2019 Jan; 39(1):73-81. PubMed ID: 30426235
[TBL] [Abstract][Full Text] [Related]
13. Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease.
Helliwell P; Coates LC; FitzGerald O; Nash P; Soriano ER; Elaine Husni M; Hsu MA; Kanik KS; Hendrikx T; Wu J; Kudlacz E
Arthritis Res Ther; 2018 Oct; 20(1):242. PubMed ID: 30373651
[TBL] [Abstract][Full Text] [Related]
14. Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study.
Coates LC; Nash P; Kvien TK; Gossec L; Mease PJ; Rasouliyan L; Pricop L; Jugl SM; Gandhi KK; Gaillez C; Smolen JS
Semin Arthritis Rheum; 2020 Aug; 50(4):709-718. PubMed ID: 32521325
[TBL] [Abstract][Full Text] [Related]
15. Enthesitis and its relationship with disease activity, functional status, and quality of life in psoriatic arthritis: a multi-center study.
Sunar I; Ataman S; Nas K; Kilic E; Sargin B; Kasman SA; Alkan H; Sahin N; Cengiz G; Cuzdan N; Gezer IA; Keskin D; Mülkoğlu C; Resorlu H; Bal A; Duruöz MT; Küçükakkaş O; Yurdakul OV; Melikoglu MA; Aydın Y; Ayhan FF; Bodur H; Calis M; Capkın E; Devrimsel G; Gok K; Hizmetli S; Kamanlı A; Keskin Y; Kocabas H; Kutluk O; Şen N; Şendur OF; Tekeoğlu I; Tolu S; Toprak M; Tuncer T
Rheumatol Int; 2020 Feb; 40(2):283-294. PubMed ID: 31773391
[TBL] [Abstract][Full Text] [Related]
16. Comparison of composite measures of disease activity in psoriatic arthritis using data from an interventional study with golimumab.
Helliwell PS; Kavanaugh A
Arthritis Care Res (Hoboken); 2014 May; 66(5):749-56. PubMed ID: 24127416
[TBL] [Abstract][Full Text] [Related]
17. Residual Disease Activity and Associated Factors in Psoriatic Arthritis.
Lubrano E; Scriffignano S; Perrotta FM
J Rheumatol; 2020 Oct; 47(10):1490-1495. PubMed ID: 31676704
[TBL] [Abstract][Full Text] [Related]
18. The Effect of the Presence of Fibromyalgia on Common Clinical Disease Activity Indices in Patients with Psoriatic Arthritis: A Cross-sectional Study.
Brikman S; Furer V; Wollman J; Borok S; Matz H; Polachek A; Elalouf O; Sharabi A; Kaufman I; Paran D; Elkayam O
J Rheumatol; 2016 Sep; 43(9):1749-54. PubMed ID: 27252430
[TBL] [Abstract][Full Text] [Related]
19. Burden of Psoriatic Arthritis According to Different Definitions of Disease Activity: Comparing Minimal Disease Activity and the Disease Activity Index for Psoriatic Arthritis.
Wervers K; Vis M; Tchetveriko I; Gerards AH; Kok MR; Appels CWY; van der Graaff WL; van Groenendael JHLM; Korswagen LA; Veris-van Dieren JJ; Hazes JMW; Luime JJ
Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1764-1770. PubMed ID: 29609220
[TBL] [Abstract][Full Text] [Related]
20. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA).
Theander E; Husmark T; Alenius GM; Larsson PT; Teleman A; Geijer M; Lindqvist UR
Ann Rheum Dis; 2014 Feb; 73(2):407-13. PubMed ID: 23355078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
